Vor Biopharma (VOR) Cash from Operations (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Cash from Operations data on file, last reported at 38246000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations fell 23.11% year-over-year to 38246000.0 in Q1 2026; TTM through Mar 2026 was 149893000.0, a 49.5% decrease from a year earlier, with the FY2025 full-year figure at 142713000.0, down 43.2% from the prior year.
• Cash from Operations for Q1 2026 stood at 38246000.0, down from 22801000.0 in the prior quarter.
• Over the last five years, Cash from Operations for VOR reached as high as 18346000.0 in Q4 2022 and fell as low as 53662000.0 in Q3 2025.
• Historically, Cash from Operations has averaged 27415000.0 across 5 years, with a median of 24100000.0 in 2023.
• Across the five-year window, Cash from Operations climbed 16.54% in 2024 and slumped 130.46% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 18346000.0 in 2022, then tumbled by 30.96% to 24026000.0 in 2023, then fell by 0.15% to 24063000.0 in 2024, then increased by 5.24% to 22801000.0 in 2025, then slumped by 67.74% to 38246000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 38246000.0 in Q1 2026, 22801000.0 in Q4 2025, and 53662000.0 in Q3 2025.